Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Apo Berymonidin and Latanoprost on Optic Nerve Head Perfusion in Normal Tension Glaucoma
IRCT20120817010617N3Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of latanoprost in normal tension glaucoma (NTG) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Optic nerve head perfusion. Started Jan 2020; status: completed.
02
Drugs
latanoprost
03
Conditions
normal tension glaucoma (NTG)
Beyond the preview
Go deeper on IRCT20120817010617N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120817010617N3.